Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 575-584

  D'Ascenzo, Fabrizio ^a   Bollati, Mario ^a   Clementi, Fabrizio ^b   Castagno, Davide ^a   Lagerqvist, Bo ^c   De La Torre Hernandez, Jose M ^d   Ten Berg, Juriën M ^e   Brodie, Bruce R ^f   Urban, Philip ^g   Jensen, Lisette Okkels ^h   Sardi, Gabriel ⁱ   Waksman, Ron ⁱ   Lasala, John M ^j   Schulz, Stefanie ^k   Stone, Gregg W ^l   Airoldi, Flavio ^m   Colombo, Antonio ⁿ   Lemesle, Gilles ^o   Applegate, Robert J ^p   Buonamici, Piergiovanni ^q   Kirtane, Ajay J ^l   Undas, Anetta ^r   Sheiban, Imad ^a   Gaita, Fiorenzo ^a   Sangiorgi, Giuseppe ^b   Modena, Maria Grazia ^s   Frati, Giacomo ^t   Biondi Zoccai, Giuseppe ^t   more..

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UPPSALA UNIVERSITY   (Sweden)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f LeBauer Cardiovascular Research Foundation   (United States)

^g LA TOUR HOSPITAL   (Switzerland)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ WASHINGTON HOSPITAL CENTER   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l NewYork Presbyterian Hospital   (United States)

^m IRCCS MULTIMEDICA   (Italy)

ⁿ EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^o LILLE UNIVERSITY HOSPITAL   (France)

^p WAKE FOREST SCHOOL OF MEDICINE   (United States)

^q CAREGGI UNIVERSITY HOSPITAL   (Italy)

^r JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^s UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^t SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Coronary artery disease; Drug eluting stent; Meta analysis; Stent; Stent thrombosis; Systematic review

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY BIFURCATION LESION; CORONARY STENT; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG ELUTING STENT; DRUG WITHDRAWAL; EQUIPMENT DESIGN; HUMAN; INCIDENCE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; STENT THROMBOSIS; STUDY DESIGN; SYSTEMATIC REVIEW;

COOPERATIVE BEHAVIOR; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; INCIDENCE; INTERNATIONALITY; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; WITHHOLDING TREATMENT;

EID: 84879077947     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.080     Document Type: Article

References (98)

1. D.R. Holmes Jr., D.J. Kereiakes, and S. Garg Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
2. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
3. J.M. de la Torre-Hernández, F. Alfonso, and F. Hernández Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 2008 986 990
4. G. Lemesle, A. De Labriolle, and L. Bonello Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents J Interv Cardiol 22 2009 228 233
5. T. Chechi, S. Vecchio, and G. Vittori ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients J Am Coll Cardiol 51 2008 2396 2402
6. M. Ergelen, S. Gorgulu, and H. Uyarel The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction Am Heart J 159 2010 672 676
7. J.M. Lasala, D.A. Cox, and D. Dobies Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries Circ Cardiovasc Interv 2 2009 285 293
8. D.E. Cutlip, D.S. Baim, and K.K. Ho Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
9. P.K. Kuchulakanti, W.W. Chu, and R. Torguson Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents Circulation 113 2006 1108 1113
10. G. Lemesle, A. Sudre, and T. Modine High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis Catheter Cardiovasc Interv 72 2008 470 478
11. P. Wenaweser, C. Rey, and F.R. Eberli Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur Heart J 26 2005 1180 1187
12. A. Farb, and A.B. Boam Stent thrombosis redux - the FDA perspective N Engl J Med 356 2007 984 987
13. S.B. King 3 rd, S.C. Smith Jr., and J.W. Hirshfeld Jr. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 117 2008 261 295
14. M.T. Roe, A.Y. Chen, and C.P. Cannon Temporal changes in the use of drug-eluting stents for patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008. Results from the CRUSADE and ACTION-GWTG registries Circ Cardiovasc Qual Outcomes 2 2009 414 420
15. G. Biondi-Zoccai, M. Lotrionte, and P. Agostoni Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes Int J Cardiol 150 2011 325 331
16. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1999 1896 1900
17. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
18. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
19. J.P.T. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration 2009 Available from www.cochrane-handbook.org (last accessed on February 11, 2011)
20. N.L. Wilczynski, R.B. Haynes for the Hedges Team Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey BMC Med 2 2004 23
21. G. Biondi-Zoccai, E. Romagnoli, and P. Agostoni Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials 32 2011 731 740
22. D.E. Cutlip, S. Windecker, and R. Mehran Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
23. J.S. Ross, G.K. Mulvey, and B. Stauffer Statistical models and patient predictors of readmission for heart failure: a systematic review Arch Intern Med 168 2008 1371 1386
24. T. Szük, M. Gyöngyösi, and N. Homorodi Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort Am Heart J 153 2007 289 295
25. T. Kimura, T. Morimoto, and K. Kozuma Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 2010 52 61
26. I. Akin, A. Bufe, and S. Schneider Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry Clin Res Cardiol 99 2010 393 400
27. A. Rabinovitz, D.M. Bier, and G.M. Wagman Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis J Invasive Cardiol 22 2010 15 19
28. A.K. Jain, C. Lotan, and I.T. Meredith Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry Heart 96 2010 848 853
29. R.J. Applegate, M.T. Sacrinty, W.C. Little, R.M. Santos, S.K. Gandhi, and M.A. Kutcher Incidence of coronary stent thrombosis based on academic research consortium definitions Am J Cardiol 102 2008 683 688
30. C. Lotan, I.T. Meredith, L. Mauri, M. Liu, M.T. Rothman E-Five Investigators Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry JACC Cardiovasc Interv 2 2009 1227 1235
31. P. Wenaweser, C. Rey, and F.R. Eberli Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur Heart J 26 2005 1180 1187
32. Z. Huczek, K.J. Filipiak, and J. Kochman Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study Thromb Res 125 2010 406 412
33. J.L. Chen, L.J. Gao, and Y.J. Yang Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results Chin Med J (Engl) 123 2010 778 781
34. C. Le Feuvre, G. Helft, and S. Cohen Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents Arch Cardiovasc Dis 101 2008 220 225
35. B. Doyle, C.S. Rihal, and C.J. O'Sullivan Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents Circulation 116 2007 2391 2398
36. H.K. Win, A.E. Caldera, and K. Maresh EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009
37. J.W. Suh, S.H. Baek, and J.S. Park Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study Am Heart J 157 2009 908 912
38. J. Daemen, P.H. van Twisk, and N. Kukreja The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129) EuroIntervention 4 2009 464 474
39. A. Kaltoft, L.O. Jensen, and M. Maeng 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol 53 2009 658 664
40. N. Kukreja, Y. Onuma, and H.M. Garcia-Garcia The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents JACC Cardiovasc Interv 2 2009 534 541
41. D.W. Park, J.D. Flaherty, and C.J. Davidson Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in asian patients Am J Cardiol 103 2009 646 652
42. P. Roy, L. Bonello, and R. Torguson Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation Am J Cardiol 103 2009 801 805
43. L.O. Jensen, M. Maeng, and P. Thayssen Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction Circ Cardiovasc Interv 1 2008 176 184
44. B. Giusti, A.M. Gori, and R. Marcucci Relation of cytochrome P450 2 C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis Am J Cardiol 103 2009 806 811
45. A.M. Gori, R. Marcucci, and A. Migliorini Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents J Am Coll Cardiol 52 2008 734 739
46. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
47. K.W. Baran, J.M. Lasala, and D.A. Cox A clinical risk score for prediction of stent thrombosis Am J Cardiol 102 2008 541 545
48. A.M. Harmsze, J.W. van Werkum, and J.M. Ten Berg CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study Eur Heart J 31 2010 3046 3053
49. G. Parodi, G. Memisha, and B. Bellandi Effectiveness of primary percutaneous coronary interventions for stent thrombosis Am J Cardiol 103 2009 913 916
50. G.Y. Song, Y.J. Yang, and B. Xu ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions? Chin Med J (Engl) 122 2009 1610 1614
51. D. Becker, P. Maurovich-Horvat, and G. Barczi Life after coronary stent thrombosis Med Sci Monit 15 2009 CR236 CR241
52. S. Del Pace, M. Boddi, and R. Rasoini Acute infection-inflammation and coronary stent thrombosis: an observational study Intern Emerg Med 5 2010 121 126
53. F. Airoldi, A. Colombo, and N. Morici Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
54. J. Aoki, A.J. Lansky, and R. Mehran Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
55. R.J. Applegate, M.T. Sacrinty, M.A. Kutcher, R.M. Santos, S.K. Gandhi, and W.C. Little 3-year comparison of drug-eluting versus bare-metal stents JACC Cardiovasc Interv 2 2009 231 239
56. B.R. Brodie, T. Stuckey, and W. Downey Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group JACC Cardiovasc Interv 1 2008 405 414
57. P. Buonamici, R. Marcucci, and A. Migliorini Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317
58. D.W. Park, S.C. Yun, and S.W. Lee Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents JACC Cardiovasc Interv 1 2008 494 503
59. M. Ergelen, H. Uyarel, and D. Osmonov Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis Clin Appl Thromb Hemost 16 2010 33 41
60. R. Hoffmann, H. Klinker, U. Adamu, M. Kelm, and R. Blindt The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use Clin Res Cardiol 98 2009 549 554
61. B. Lagerqvist, J. Carlsson, and O. Fröbert Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry Circ Cardiovasc Interv 2 2009 401 408
62. G. Lemesle, C. Delhaye, and A. Sudre Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome Am Heart J 157 2009 375 382
63. J. Machecourt, N. Danchin, and J.M. Lablanche Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508
64. G.J. Mishkel, A.L. Moore, S. Markwell, and M.E. Shelton Correlates of late and very late thrombosis of drug eluting stents Am Heart J 156 2008 141 147
65. L.O. Jensen, H.H. Tilsted, and P. Thayssen Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry EuroIntervention 5 2010 898 905
66. T.L. Pinto Slottow, D.H. Steinberg, and P.K. Roy Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period Am J Cardiol 102 2008 298 303
67. M.J. Rinaldi, A.J. Kirtane, and R.N. Piana Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events Am Heart J 155 2008 654 660
68. G. Sarno, S. Garg, and Y. Onuma The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial) Am J Cardiol 105 2010 475 479
69. S. Schulz, T. Schuster, and J. Mehilli Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
70. P.W. Serruys, Y. Onuma, and S. Garg 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
71. J.J. Smit, A.W. van't Hof, and M.J. de Boer Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction Thromb Haemost 96 2006 190 195
72. T.R. Tolleson, L.K. Newby, and R.A. Harrington Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials) Am J Cardiol 92 2003 330 333
73. A. Undas, J. Zalewski, and M. Krochin Altered plasma fibrin clot properties are associated with in-stent thrombosis Arterioscler Thromb Vasc Biol 30 2010 276 282
74. P. Urban, A.H. Gershlick, and G. Guagliumi Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry Circulation 113 2006 1434 1441
75. J.W. van Werkum, A.A. Heestermans, and A.C. Zomer Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
76. R. Waksman, A.N. Buch, and R. Torguson Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry) Am J Cardiol 100 2007 45 51
77. Z.J. Wang, Y.J. Zhou, and Y.Y. Liu Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents Heart 95 2009 1587 1592
78. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
79. B.P. Yan, S.J. Duffy, and D.J. Clark Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry) Am J Cardiol 101 2008 1716 1722
80. S.D. Collins, R. Torguson, and M.A. Gaglia Jr. Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era? Circulation 122 2010 1085 1090
81. P. Agostoni, E. Kedhi, S. Verheye, P. Vermeersch, and G. Van Langenhove Dissimilar relevance given to diseases by medical literature, and the potential to create biases in the clinical decision-making process: the case of late stent thrombosis Int J Cardiol 114 2007 E38 E39
82. L. Venkitachalam, Y. Lei, and J.M. Stolker Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter evaluation of drug eluting stents and ischemic events (EVENT) registry Circulation 124 2011 1028 1037
83. G.G. Biondi-Zoccai, G.M. Sangiorgi, and A. Chieffo Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era Am J Cardiol 95 2005 1466 1468
84. F. Alfonso, A. Suárez, and D.J. Angiolillo Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459
85. G.M. Sangiorgi, F. Clementi, C. Cola, and G. Biondi-Zoccai Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "it's a long way to tipperary"? Catheter Cardiovasc Interv 70 2007 203 210
86. J. Hou, H. Qi, and M. Zhang Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study Heart 96 2010 1187 1190
87. P. Agostoni, P. Vermeersch, M. Knaapen, and S. Verheye Stent thrombosis is not always stent thrombosis: de novo atherosclerosis in a stented coronary segment Int J Cardiol 144 2010 E19 E21
88. G.G. Biondi-Zoccai, P. Agostoni, and G.M. Sangiorgi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation Eur Heart J 27 2006 540 546
89. P.B. Berger, N.S. Kleiman, and M.J. Pencina Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry JACC Cardiovasc Interv 3 2010 920 927
90. G.Y. Lip, K. Huber, and F. Andreotti Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting Thromb Haemost 103 2010 13 28
91. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
92. T. Bauer, H.J. Bouman, J.W. van Werkum, N.F. Ford, J.M. ten Berg, and D. Taubert Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis BMJ 343 2011 d4588
93. I. Sheiban, A. Gerasimou, and M. Bollati Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease Catheter Cardiovasc Interv 73 2009 25 31
94. D.W. Park, S.W. Lee, and S.C. Yun A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation J Am Coll Cardiol 58 2011 2630 2639
95. G.G. Biondi-Zoccai, P. Agostoni, C. Moretti, E. Meliga, and I. Sheiban Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents EuroIntervention 3 2007 381 385
96. L. Testa, W.J. Van Gaal, and G.G. Biondi Zoccai Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition QJM 102 2009 369 378
97. I. Ahmed, A.J. Sutton, and R.D. Riley Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey BMJ 344 2012 d7762
98. I. Olkin, and A. Sampson Comparison of meta-analysis versus analysis of variance of individual patient data Biometrics 54 1998 Mar 317 322